Stock listing

Oncopeptides Ab

Selected listing: ONCO · OMXSTO · SEK · SE

Oncopeptides Ab (Stockholm:ONCO), Health Technology. Latest release May 26, 2026: Oncopeptides signs agreement with Salus for distribution…

ONCO:OMXSTOSEKSEUpdated October 3, 2026

Ticker: Stockholm:ONCO
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Stockholm
Currency: SEK

About Oncopeptides Ab

Oncopeptides Ab is a public company traded on the Swedish market under the ticker ONCO. Oncopeptides focuses on developing innovative therapies for cancer treatment.

Latest news from Oncopeptides Ab

Oncopeptides signs agreement with Salus for distribution and commercialization of Pepaxti in Central and Eastern Europe

May 26, 2026

Oncopeptides (Q1 Update): Strong Quarterly Growth and Decreased Costs

May 20, 2026

Oncopeptides secures regulatory approval to start Window-of-Opportunity study in glioblastoma from Norwegian authorities

May 19, 2026

Oncopeptides publishes Q1 report 2026

May 13, 2026

Oncopeptides intends to submit type II variation to expand Pepaxti label to include third line treatment

May 11, 2026

All Oncopeptides Ab news →

Events

Replays

Oncopeptides AB (publ) (ONCO) Q2 2026 Earnings Call
Thu, Aug 27, 2026 · 03:00 AM ET
Watch
Oncopeptides AB (publ) (ONCO) Q1 2026 Earnings Call
Wed, May 13, 2026 · 03:00 AM ET
Watch
Oncopeptides AB (publ) (ONCO) Q4 2025 Earnings Call
Thu, Feb 19, 2026 · 03:00 AM ET
Watch

Research Oncopeptides Ab

Oncopeptides Ab company profile

View the public company page for Oncopeptides Ab on 6ix.

Oncopeptides Ab news

Read company news and market updates connected to Oncopeptides Ab.

Oncopeptides Ab investor events

Find investor webinars, events, and replay context for Oncopeptides Ab.